Alterity Therapeutics Limited

Oncology research and development has consistently seen significant growth around the world in the past few years, but trial diversity, and especially inclusion of Black and Hispanic patients, has con

Inhibikase Therapeutics, Inc. is back in the race to develop a drug to treat multiple system atrophy (MSA) now that the US Food and Drug Administration has lifted a full clinical hold on IkT-148009,

Company Changes AGARWAL , Sunil, MD To: Juno Therapeutics Inc. , Pres., R&D (April) From: Ultragenyx Pharmaceutical Inc., EVP, CMO Phone: 206-582-1600 AL-WAKEEL Yasir To: Neon Therapeutics

Prana Biotechnology Ltd. has named David Stamler chief medical officer and senior vice president, clinical development. Stamler was previously vice president, clinical development and therapeutic